Renibus Therapeutics announces new CEO and close of $35 million Series A funding
February 17, 2022 at 00:32 AM EST
According to the release, Stonebanks served as an advisor to Renibus before his appointment, leveraging his expertise as a repeat biotech CEO to help guide the company’s development.
